Page 2 - Advanced Solid News Today

- Nectin Therapeutics Ltd., (Nectin) a biotechnology company has extended its Series A financing to over $25M for immuno-oncology therapies

/PRNewswire/ -- Grey Wolf Therapeutics, a biotechnology company focused on generating entirely novel anti-tumour immune responses through targeted cancer...

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Investegate announcements from NuCana plc, NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022

Molybdenum disulfide is the main component of molybdenite. Black solid powder with metallic luster.

REHOVOT, Israel, Aug. 04, 2022 -- Purple Biotech Ltd. , a clinical-stage company developing first-in-class, effective and durable therapies by harnessing the power of the tumor microenvironment to... | August 4, 2022

- CYT-0851 has demonstrated broad clinical activity and a generally well tolerated safety profile in a heavily pretreated population of patients - Dur

/PRNewswire/ -- Harbour BioMed (the "Company", HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.